DASH Diet Effect in Patients with Non‑Alcoholic Fatty Liver Disease

Informative video-capsule presenting the findings of a randomized controlled trial that evaluated the effect of dietary approaches to stop hypertension (DASH) on hepatic fibrosis, hepatic steatosis, and liver enzymes in 67 patients with non-alcoholic fatty liver disease (NAFLD), which were assessed during 12 weeks by transient elastography and serum concentrations of alanine aminotransferase (ALT), aspartate transaminase (AST) & gamma-glutamyl transpeptidase (GGT).

Source:
Sangouni AA, Nadjarzadeh A, Rohani FS, Sharuni F, Zare Z, Rahimpour S, et al. Dietary approaches to stop hypertension (DASH) diet improves hepatic fibrosis, steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Eur J Nutr. 2023. doi:10.1007/s00394-023-03221-w. Epub ahead of print. Approved Article: https://viatris-digitalassets.s3.eu-central-1.amazonaws.com/gr/general/GASTRO_Dietary_approaches_to%C2%A0stop_hypertension_diet.pdf

Music copyrights: 
Dance Of The Gypsies by Hanu Dixit from YouTube Audio Library http://goo.gl/YmnOAx

IN-NON-2024-00103